Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Onions may help reduce cancer risk and obesity-related issues.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

SOX4 is crucial for the development of melanoma.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

A man developed a painful skin condition after multiple heart procedures involving radiation.

The document emphasizes early detection and treatment of men's skin conditions and recommends protective measures and appropriate treatments for different age groups.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Men in the U.S. have more health issues, higher death rates from various diseases, lower life expectancy, and are less likely to seek healthcare.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.